Objectives. To develop and assess the effectiveness of a drug information leaflet (DIL) for D-penicillamine (DPA) and determine whether additional verbal information provides enhanced benefit. Methods. Three preliminary studies were undertaken: a reading age study; the development of a DIL for DPA; and a DPA knowledge questionnaire. The primary study assessed the effect of the DIL on the knowledge of 30 patients at weeks 0 and 24 after commencing DPA. A follow-up study of 100 patients randomly assigned to receive the DIL alone (control group) or with additional verbal backup (experimental group) determined the effects of additional verbal information by comparison of DPA knowledge questionnaire scores at weeks 0 and 24.
The majority of health professionals believe that providing patients with information about their disease and treatments is an important aspect of their care. Indeed, in a recent editorial Etchells w1x stated that the provision of information is considered to be a fundamental ethical, legal and professional obligation. Information is particularly important for those who are diagnosed with a chronic and complex disease such as rheumatoid arthritis (RA). This is because the effective management of RA necessitates a large component of self-care w2x, and self-care requires a level of knowledge that few patients acquire without additional information. Several studies have shown widespread lack of knowledge in patients with RA w3-5x, and patients themselves do not believe that they receive all the information they need w6x. This was highlighted in work on clinical communication undertaken by the Audit Commission in 1993 w7x in which RA was used as one of the tracer conditions. Patients were dissatisfied with information about their drugs, aids and appliances, local support groups and disabled access to hospitals.
Drug therapy plays an important role in the management of RA, but research shows that information is either not provided at all w8x or that communication between patient and care-provider is ineffective w9x. Whatever the reasons for this omission, the emphasis on providing information in the UK has changed with the publication of the Patient's Charter w10x. Hospitals are now required to give patients full information about treatments, their risks and alternatives. Many health professionals rely on a verbal explanation, but this has been shown to be ineffective; patients tend to forget approximately half of the information they are given w11x. One method of providing information is to supply written material. This method has been shown to increase patients' knowledge of the organization of general practice w12x and of their disease w13, 14x. Furthermore, this knowledge is retained over a number of months w15x. Patient information leaflets have also been shown to increase knowledge of drug side-effects in a series of studies undertaken in the community w16, 17x. These studies included information about non-steroidal antiinflammatory drugs (NSAIDs) but there is little information on the effectiveness of drug information leaflets (DIL) for disease-modifying anti-rheumatic drugs (DMARDs).
The primary purpose of this study was to test the effectiveness of a DIL for D-penicillamine (DPA), which was to be used in a study of adherence in which the DIL was an essential component w18x. A second aim was to assess whether additional verbal information enhanced any increase in knowledge.
Patients and methods

Preliminary work
Before the primary study was undertaken, three preliminary studies were carried out. In preliminary study 1, the reading ability of 100 consecutive patients with RA who were attending the rheumatology out-patient clinics at Leeds General Infirmary for follow-up appointments was assessed by use of the Holborn Reading Scale w19x. Their demographic data are displayed in Table 1 ; by chance all were Caucasian. The results showed that 12% of the sample had a reading age of 13 yr or below (Table 2) , necessitating preliminary study 2, an assessment of the readability of the DIL used.
In preliminary study 2, 10 consecutive patients (Table 1 ) attending the rheumatology clinic who had been newly prescribed DPA read the existing DPA leaflet intended for use in the primary study and found it difficult to read. It was therefore subjected to the Flesch Reading Index w20x. The patients' assessments were upheld by the results of applying the index, which placed it in the 'fairly difficult to read' range. The DIL was rewritten using guidelines that render information easier to read w21x and using the ARC information sheet as a proforma. The ARC sheet was considered for use, but it was not suitable as it did not specify dose, the frequency of blood and urine tests or contact phone numbers, all imperatives for the adherence study. After four revisions, a Flesch reading ease score of 80.1 and a grade level of 4.7 was attained, placing it in the 'fairly easy to read' category, and in the light of the results from preliminary study 1 it was considered suitable for use.
In preliminary study 3, a DPA questionnaire was designed using a format and layout similar to that of the Patient Knowledge Questionnaire w4x. All 14 correct answers could be found in the DPA DIL. The questionnaire was tested on 10 patients whose demographic data are shown in Table 1 . None experienced problems with its readability or layout, and all thought that the DIL answered all the questions they would raise when starting a new DMARD. The median score was 12.5 and the scores ranged from 6 to 14.
Primary study
This study comprised an assessment of knowledge of DPA. The cohort was a convenience sample comprising 30 consecutive RA patients who had been newly prescribed DPA (for demographic details see Table 1 ).
Method of assessment. The patients were asked to complete the DPA questionnaire and were then given the DPA DIL and their prescription. No verbal information about DPA was proffered and after 24 weeks they completed the DPA questionnaire again. These results were compared with the week 0 data.
Follow-up study
This study assessed the value of providing additional verbal backup to the DPA DIL. One hundred patients with RA who were about to start DPA were referred by the rheumatologists in the rheumatology out-patient clinic. The demographics of the sample are shown in Table 1 . 
Method of assessment. An independent assessor invited patients to take part in the study and none declined. Patients were then randomized via a computer-generated code into two groups, both being seen by the same nurse practitioner (JH). The experimental group received a DPA DIL plus a verbal explanation about their drug, and the controls were provided with the DIL alone. Randomization resulted in 51 patients in the experimental group and 49 patients in the control group. Knowledge of DPA was tested by use of the DPA questionnaire, which was provided by an independent assessor who was unaware of the group to which each patient belonged. Patients completed the DPA questionnaire on study admission (week -2) and again after 24 weeks.
Analysis
The study included both descriptive and inferential statistics. Analysis was performed using the Statistics Package for Social Sciences (SPSS Inc., Chicago, IL, USA). As the data were not normally distributed, two-tailed non-parametric statistics were applied. The Mann-Whitney U-test was used for comparison between groups and the Wilcoxon rank sum test was used to assess the significance of changes within groups. The 1% level of significance was adopted.
Results
Assessment of knowledge of DPA
During the 6 months of the study, six patients withdrew due to side-effects from DPA, leaving a total of 24 pairs of DPA questionnaires suitable for analysis. As expected, on entry to the study the majority of patients knew very little about DPA; the median score was 2 (range 0-13). Seven patients (29%) scored 0u14, four (17%) scored 1u14 and three (13%) scored 2u14. These patients constituted 59% of the total cohort. Conversely, three patients scored over 50%, one scored 8, one scored 11 and one patient scored 13u14 points. After 24 weeks patients had increased their knowledge of DPA, the lowest score being 6u14 (one patient), the highest was 13 points, scored by eight patients. The median score was now 10. These increases were statistically significant P < 0.0001).
Assessment of additional verbal backup
As expected, neither group knew much about DPA on study entry, the mean score of the experimental group being 2.80 and that of the controls 2.57 (Table 3) . There was wide variation between individual patients. The range of scores was from 0 to 8 in the control group and 0 to 14 in the experimental group. However, there was no significant difference in the knowledge of the two groups at week 0 (P=0.791). By week 24 both groups had increased their scores, the experimental group scoring a mean of 10.80 and the controls 9.90 (Table 3) . Both groups knew significantly more about DPA on completion of the study than at the start (P < 0.001). By the end of the research, patients in the experimental group who had received additional verbal information knew more about their DPA and its effects than those in the control group, but the difference between the two groups was not significant (P = 0.109).
Discussion
This research has highlighted several important aspects with regard to the provision of information. It found that a large minority of patients with RA have problems with their reading. This applied to 12% of the patients in this study, similar to the proportions in the general population w22x and other RA studies w23x. These patients would find it difficult to read much of the educational literature presently provided. This highlights the necessity of testing the readability of all educational material, including DILs, before it is presented to patients. The practice of applying reading formulae to written information is effective, but these tools should not be seen as a universal panacea as they have their limitations and may provide a false sense of validity because of the apparent precision of the tools. For instance, they are designed to assess samples of 100 words towards the beginning, middle and end of a document; they do not assess each word within it. This can lead to great variability in reading age within the same document w24x. The application of common sense to the content and presentation, in conjunction with the opinions of patients, is also essential in designing literature that is easily understood w25x.
The second finding was that the DIL written at an easily readable level was a highly effective method of increasing the patient's knowledge of the effects and side-effects of their DPA. The provision of such information empowers patients to become more involved in the decision-making process and this is in keeping with NHS priorities. The provision of information about drug therapies has received greater attention since the EC Directive 92u27 w26x came into force in January 1999. This makes it mandatory that all medicines are supplied with a comprehensive information leaflet produced by the manufacturer. Each leaflet must contain all the information given in the Summary of Product Characteristics (formerly called the DATA Sheet), making it necessary to use extremely small print on thin paper that is multiply folded w27x. This causes difficulty for those with impaired dexterity or poor vision. There is surprisingly little research into the effectiveness of these manufacturer's inserts, but one study has shown that many patients remain unaware of them, and only a minority will read even a part of the Finally, although additional verbal explanation of DPA did enhance patient knowledge, it did not have a significant effect. This finding is in line with the results of another recently published study on NSAIDs w29x. In general, the literature on information-giving advocates the combination of written and verbal information. One author cites it as the ideal, as it maximizes the patients' recall and understanding, and is preferred by patients w30x. One explanation for the lack of enhancement in this study is that the additional verbal backup was unintelligible to patients. However, the nurse who provided the explanation is an experienced practitioner who has been shown in previous research to be an expert communicator w13x. A second and more likely reason could be that the questions on the DPA questionnaire were designed specifically from the information provided on the DPA DIL. It may well be that an additional verbal explanation simply did not furnish the patients with a significant amount of further information.
Limitations of the study
With the advent of new drugs, DPA is not now widely used. However, this work formed part of a wider investigation of adherence in which DPA was used for methodological reasons. Its use in preference to more commonly used drugs should not invalidate the underlying scientific principles of this study.
Although improving patients' knowledge of their drug therapies is a laudable aim, it is acknowledged that knowing and understanding are different entities and consequently it cannot be assumed from the results of this study that knowledge led to changes of behaviour. However, our subsequent study of adherence showed that behavioural changes did occur w18x, and that patients who were provided with information were significantly more adherent with their DPA therapy.
One other caveat is that by chance all the patients in this study were Caucasians and so the results may not reflect the reading ability of other ethnic groups.
